BOSTON, Feb. 8, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services. A new ancillary warehouse in the greater Boston, Massachusetts area in the United States and a significantly enlarged depot ... read more

BOSTON, Feb. 6, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Ramita Tandon, Global Head, Late Phase Clinical Trials and Lars-Olof Eriksson, Ph.D., MS.c., Vice President, Global Research Operations at PAREXEL will address innovative approaches to late stage development at the ... read more

BOSTON and SEOUL, Korea, Feb. 1, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced today that it has entered into an agreement with ASAN Medical Center (AMC), based in Seoul, Korea. The alliance offers clinical trial sponsors based regionally and ... read more

BOSTON, Jan. 30, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the second quarter ended December 31, 2011. For the three months ended December 31, 2011, PAREXEL's consolidated service revenue increased by 9.5% to $333.2 million compared with $304.4 million in the prior year period. ... read more

BOSTON, Jan. 23, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, announced today that it has established an alliance with University Hospitals Bristol National Health Service (NHS) Foundation Trust (UH Bristol), one of the largest specialist teaching and research hospital trusts ... read more

BOSTON, Jan. 18, 2012 /PRNewswire/ -- Perceptive Informatics®, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that its medical imaging services were among the top rated of its peer services in an independent survey on the medical imaging ... read more

BOSTON, Jan. 17, 2012 /PRNewswire/ -- PAREXEL Consulting, a business unit of PAREXEL International (NASDAQ: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that David Elder, formerly a senior official of the U.S. Food and Drug Administration (FDA), has ... read more

BOSTON, Jan. 9, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the J. P. Morgan Healthcare Conference in San Francisco at 2:30 p.m. PT on Wednesday, January 11, 2012. A live webcast of the presentation will be available ... read more

BOSTON, Jan. 3, 2012 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Second Quarter of Fiscal Year 2012 on Monday, January 30, 2012 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and ... read more

BOSTON, Dec. 21, 2011 /PRNewswire/ -- To help emerging and mid-size biopharmaceutical companies address an increasingly challenging regulatory and commercial environment, PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it is introducing a series of executive briefings with clinical operations and outsourcing leaders worldwide. ... read more

BOSTON, Dec. 19, 2011 /PRNewswire/ -- Perceptive Informatics®, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that its DataLabs® Electronic Data Capture (EDC) solution has been implemented by 15 of the top 35 global biopharmaceutical companies. The award-winning solution ... read more

BOSTON, Dec.15, 2011 /PRNewswire/ -- As the biopharmaceutical industry continues to migrate toward the use of more seamless eClinical solutions to accelerate clinical development, Perceptive Informatics, a leading eClinical solutions provider and subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), has reached a milestone of completing more than ... read more

BOSTON, Nov. 29, 2011 /PRNewswire/ -- Perceptive Informatics(®), a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced that its DataLabs® Electronic Data Capture (EDC) solution ranked highest among EDC solutions for overall satisfaction in ISR's 2011 The State of ... read more

BOSTON, Nov. 23, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has appointed several executives to its global team of late phase and observational research experts in PAREXEL's PACE(TM) (Peri-Approval Clinical Excellence) group. This team will help sponsors collect the ... read more

BOSTON, Nov. 22, 2011 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has enhanced its central nervous system (CNS) capabilities for clinical development through the implementation of functional magnetic resonance imaging (fMRI) technology in its Early Phase units. This advanced imaging scanning ... read more

BOSTON, Nov. 21, 2011 /PRNewswire/ -- Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), today announced results of a global survey conducted during its webinar entitled "Medical Imaging Web Reporting: Helping Sponsors Simplify Central Imaging Study Management through Metrics." ... read more

BOSTON, Nov. 15, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has been selected as one of two strategic partners by UCB, a global biopharmaceutical company, to provide clinical development services worldwide. PAREXEL will work with UCB ... read more

BOSTON, Nov. 7, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Lazard Capital Markets Healthcare Conference in New York. Josef von Rickenbach, Chairman and Chief Executive Officer will be making a presentation on PAREXEL at 11:30 a.m. ET on Tuesday, ... read more

BOSTON, Nov. 2, 2011 /PRNewswire/ -- Commercialization experts from PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, will discuss how to maximize product value through launch and over the entire product lifecycle at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 14th Annual European Congress, to ... read more

BOSTON, Oct. 31, 2011 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) today announced its financial results for the first quarter ended September 30, 2011. For the three months ended September 30, 2011, PAREXEL's consolidated service revenue increased by 6.4% to $314.7 million, compared with $295.8 million in the prior year period. ... read more